“Chronic diseases represent the most critical market in medical technology. Incredible innovation is taking place across the industry in how med tech both treats and interacts with patients." -Brian Johnson, Publisher, MassDevice
(PRWEB) October 10, 2013
MassDevice, an online journal of the medical devices industry, is pleased to announce the 2013 MassDevice Big 100 West, an evening of insight into how decisions are made at the highest level of the medical device industry, and what challenges and new opportunities are opening up within the field.
The event, which will be held at the Hyatt Regency Irvine, Calif., on December 10, from 4 p.m. to 8 p.m. EST, will focus on medical devices and the future of treating chronic diseases, as well as the opportunities for businesses to solve those problems. The event welcomes an incredible panel of industry leaders and executives, each of whom has left their own important mark on the medical device industry.
Featured speakers include:
- Rick Altinger, CEO of Glooko. Mr. Altinger previously worked at Intuit, where he led the creation of the patient portal system; served as Executive Vice President at AdvancedMD, and was also an early employee at Healtheon/WebMD where he served as Vice President of Business Development.
- Mark Carlson, Chief Medical Officer of St. Jude Medical. Carlson has chaired several policy committees and conferences sponsored by the Heart Rhythm Society and the FDA, as well as a task force that developed policy recommendations on pacemaker and ICD performance and industry communications.
- Michael Farrell, CEO of ResMed. Farrell has served as the Company’s president – Americas since May 2011. He was previously senior vice president, strategic business unit – sleep from July 2007 to May 2011, and before that role he was vice president, marketing for the Americas from June 2005 through July 2007, and vice president, business development.
- Dr. Robert Greenberg, CEO and Founder of Second sight, the creator of the world’s first bionic eye. Dr. Greenberg has worked in the field of retinal prosthetics for over twenty years. From 1991 to 1997, Dr. Greenberg conducted pre-clinical and clinical trials demonstrating the feasibility of retinal electrical stimulation to elicit visual perceptions. From 1997 to 1998, he served as a medical officer and lead reviewer for IDEs and 510(k)s at the Office of Device Evaluation at the U.S. Food and Drug Administration in the Neurological Devices Division.
Panel discussions with all the CEOs in attendance will be moderated by MassDevice publisher Brian Johnson and David Gollaher, President and CEO of the California Healthcare Institute.
“Chronic diseases represent the most critical market in medical technology,” MassDevice publisher Brian Johnson said. “Incredible innovation is taking place across the industry in how med tech both treats and interacts with patients. However, changes in payment models from Obamacare will necessitate a new approach to the business model of this industry. We’re thrilled to welcome such an accomplished panel of leaders to discuss the future of the space.”
Covidien has underwritten the Big 100 West event, which is sponsored by aptitude, J29 Associates, KHJ Brand Activation, Porzio Life Sciences, Greenberg Traurig,HCB Health, and is partnered with the CHI. Additional support comes from OCTANe, BioCom, and AdvaMed 2014. All parties interested in attending the conference must register through the MassDevice Big 100 West EventBrite page.
MassDevice.com provides news and information for the medical device industry and the companies that drive it. Recognized throughout the med-tech industry as a go-to source for originally-reported, quality news coverage, MassDevice reaches more than 75,000 readers each month through its flagship website and email newsletters
Since 2009, MassDevice has been the online journal of the medical devices industry, with hour-to-hour coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.